Company Size
11 - 50 employees
Year Founded
2012
About Casdin Capital
Great medicines make great investments, and Casdin Capital invests in all aspects of today’s Life Sciences revolution.
The companies we work with are putting to use the incredible knowledge base unlocked by the accelerating capability to read and manipulate molecular information. Spanning Healthcare, Biotechnology, Synthetic Biology, and Technology, our sector is dynamic and complex.
Casdin Capital approaches this space by partnering with companies and building positions to create value and open new opportunities. Big returns require patience and persistence, and strong relationships. Due to decades of participation and practice, Casdin Capital is among the few expert investors in the field. Yet our basic formula remains the same: Take aim at big markets; Invest in great ideas and great teams; Stay focused; Avoid hubris.
Financials Beta
Business Model: Not Specified
Revenues: Not Specified
Expenses: Not Specified
Debt: Request
Operating Status: Active
Funding Raised: $0
Investment Rounds: 0 Rounds
Funding Stage: Not Specified
Last Funding Date: Not Specified